[IgA脏病] 这是一个很好的方法
1Medizinische Klinik II, Uniklinik der RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland. jfloege@ukaachen.de.
Innere Medizin (Heidelberg, Germany)
|September 6, 2023
概括
IgA脏病 (IgAN) 是一种常见的脏疾病,通常是晚诊断的. 尼菲康为高风险患者提供了一种新的向治疗,其他疗法正在开发中.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- IgA脏病 (IgAN) 是最常见的原发性淋巴结核炎,其特征是IgA1沉积在淋巴结核中.
- 疾病的发病因子尚未完全理解,涉及异常的IgA1循环和沉积导致炎症.
- 伊格纳通常呈现无症状,诊断通常发生在功能受损时脏活检时.
研究的目的:
- 审查目前对IgA病变 (IgAN) 病原和临床表现的理解.
- 讨论IGAN的预后指标和当前治疗策略.
- 突出新疗法发展,包括Nefecon和正在进行的临床试验.
主要方法:
- 关于IgA脏病 (IgAN) 病原,临床过程和治疗的文献综述.
- 分析预后因素,如蛋白尿和损伤.
- 评估现有和新兴的治疗方案,包括皮质类固醇和Nefecon.
主要成果:
- IgAN 诊断通常是延迟的,蛋白尿和损伤是预后的关键指标.
- 由于副作用,欧洲IgAN患者的全身皮质类固醇疗效受到争议.
- 尼菲康 (封装布迪索尼德) 是首个批准用于高风险Igan患者的向治疗.
结论:
- 需要更好地了解IgA病 (IgAN) 的起源和早期诊断.
- 治疗策略正在不断发展,Nefecon代表了高风险个体的重大进步.
- 目前正在进行的临床试验正在探索新的方法,以有效地管理Igan.
更多相关视频
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
23.7K
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.8K
相关概念视频
Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Nephrons
2.7K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.7K
Acute Kidney Injury II: Pathophysiology
26
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
26
Acute Kidney Injury I: Introduction
28
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
28
Acute Kidney Injury III: Clinical Manifestations
29
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
29
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
